-- ALL -- General Surgery Gynecology Robotic Surgery Urology WLH

Endometriosis: Pathophysiology, Clinical Manifestations, and Management

Gynecology / Feb 4th, 2026 11:01 am A⁺ | a^-

Date & Time:

14 October 2024 | 14:30 IST

Lecture Handout Prepared from the Teaching Session by: Dr. R. K. Mishra

SUMMARY:

This comprehensive lecture series offers postgraduate surgeons and gynecologists a thorough understanding of endometriosis, from its fundamental pathophysiology to its clinical management. The series begins by defining endometriosis as the presence of functional endometrial tissue outside the uterine cavity, highlighting its paradoxical nature as a histologically benign but clinically invasive disease. It explores the multifactorial etiopathogenesis, with a focus on Sampson's theory of retrograde menstruation, coelomic metaplasia, and the influence of genetic, immunologic, and environmental factors. The lectures detail the clinical presentation, centered on the classic triad of dysmenorrhea, dyspareunia, and infertility, and review the diagnostic workup, establishing laparoscopy as the gold standard. A significant portion is dedicated to a patient-centered management framework, covering expectant, medical, and surgical options tailored to the patient's symptoms and fertility goals. Surgical techniques, from conservative laparoscopic excision and endometrioma cystectomy to definitive hysterectomy, are discussed, along with the management of special-site endometriosis and the high rate of disease recurrence.

KEY KNOWLEDGE POINTS:

Definition, histological criteria, and paradoxical characteristics of endometriosis.
Etiopathogenetic theories, including retrograde menstruation, coelomic metaplasia, and immunologic factors.
Pathology of endometriotic implants, endometrioma formation, and deep infiltrating endometriosis (DIE).
The American Society for Reproductive Medicine (ASRM/AFS) staging system.
The classic clinical triad: progressive secondary dysmenorrhea, infertility, and deep dyspareunia.
Diagnostic pathway, including physical examination, imaging (ultrasound, MRI), and laparoscopy as the gold standard.
Principles of management: expectant, medical, and surgical therapies tailored to patient needs.
Medical treatments aimed at inducing pseudo-pregnancy or pseudo-menopause.
Conservative and definitive surgical techniques, including laparoscopic cystectomy for endometriomas.
Management of scar endometriosis and the high rate of disease recurrence.

INTRODUCTION:

Endometriosis is a complex, chronic, estrogen-dependent inflammatory disease characterized by the growth of endometrial-like tissue outside the uterine cavity. Despite its benign histology, the condition exhibits malignant-like clinical behavior, including local invasion and dissemination, leading to significant morbidity through chronic pelvic pain, organ dysfunction, and infertility. Its enigmatic nature, with a poor correlation between disease extent and symptom severity, presents considerable diagnostic and therapeutic challenges for gynecologists. A thorough grasp of its multifactorial pathogenesis, varied clinical manifestations, and structured management principles is essential for accurate diagnosis, effective long-term treatment, and improving the quality of life for the millions of women affected by this condition.

LEARNING OBJECTIVES:

To define endometriosis and describe the primary theories of its etiopathogenesis.
To identify the common anatomical sites, clinical features, and physical signs of endometriosis.
To understand the diagnostic pathway, including the roles of imaging and laparoscopy, and apply the ASRM staging system.
To formulate a comprehensive, individualized management plan incorporating medical and surgical therapies based on patient symptoms and fertility goals.

CORE CONTENT:

1. Definition and Core Characteristics

1.1 Definition

Endometriosis is defined as the presence of functioning endometrial tissue, comprising both glands and stroma, at sites other than the uterine mucosa. This ectopic tissue responds to cyclical hormonal stimulation, leading to proliferation and bleeding, which incites a chronic inflammatory response. This condition is also termed "endometriosis externa" to distinguish it from "endometriosis interna" or adenomyosis, where endometrial tissue is found within the uterine myometrium.

1.2 A Disease of Contrast

Endometriosis exhibits several paradoxical features:

Benign but Invasive: While histologically benign, implants are locally invasive, can disseminate widely, and affect quality of life profoundly.
Hormonal Response: The disease is estrogen-dependent and stimulated by cyclical hormones, yet it is therapeutically suppressed by continuous hormonal administration (which creates a stable, non-cyclical environment).
Symptom-Severity Discrepancy: There is a poor correlation between the anatomical extent of the disease and the severity of symptoms. Minimal disease can cause incapacitating pain, while extensive disease may be asymptomatic.

2. Epidemiology and Risk Factors

2.1 Prevalence

The prevalence of endometriosis is increasing, attributable to both:

True Increase: Associated with modern lifestyle trends like delayed childbearing and smaller family sizes, which increase a woman's lifetime number of menstrual cycles.
Apparent Increase: Resulting from heightened awareness and improved diagnostic capabilities, particularly the use of laparoscopy.

It affects an estimated 10–15% of women in the reproductive age group and 30–45% of women with infertility.

2.2 Risk Factors

Reproductive Factors: Low parity, early menarche, late menopause, and delayed childbearing.
Genetic Factors: A familial predisposition exists, with increased incidence among first-degree relatives.
Anatomical Factors: Genital outflow tract obstruction (e.g., imperforate hymen) increases retrograde flow.
Physical Factors: Paradoxically, a low Body Mass Index (BMI) is often associated with endometriosis.
Environmental/Peritoneal Factors: Exposure to toxins like dioxins and an altered peritoneal fluid environment (e.g., elevated interleukins IL-1, IL-6, IL-8) may promote implant survival.

3. Etiopathogenesis

The etiology is multifactorial, with several proposed theories:

Sampson's Theory of Retrograde Menstruation: The most widely accepted theory, proposing that viable endometrial cells flow backward through the fallopian tubes during menstruation and implant on pelvic surfaces.
Coelomic Metaplasia Theory: Suggests that peritoneal mesothelium can transform into endometrial-like tissue, possibly triggered by chronic irritation from retrograde menstrual blood.
Direct Implantation Theory: Explains scar endometriosis, where endometrial tissue is iatrogenically implanted during procedures like cesarean sections or episiotomies.
Lymphatic and Vascular Dissemination (Halban’s Theory): Proposes that endometrial tissue can metastasize to distant sites like the lungs and pleura.
Immunological and Genetic Factors: A compromised immune system may fail to clear ectopic endometrial cells, allowing them to implant and proliferate in genetically susceptible individuals.

4. Pathology and Disease Progression

Ectopic endometrial tissue responds to cyclical estrogen, leading to proliferation, bleeding, and a chronic inflammatory response. This results in fibrosis, adhesion formation, and peritoneal "puckering."

Deep Infiltrating Endometriosis (DIE): Defined by lesion penetration >5 mm beneath the peritoneal surface.
Endometrioma ("Chocolate Cyst"): An ovarian cyst formed from repeated cyclical bleeding of an intra-ovarian implant. The retained blood degrades into a thick, dark brown, tar-like fluid.

5. Anatomical Sites and Classification

5.1 Anatomical Sites

Common Sites: Ovaries (most common), pelvic peritoneum (Pouch of Douglas, uterosacral ligaments), rectovaginal septum, and sigmoid colon.
Rare Sites: Surgical scars (cesarean, episiotomy, umbilicus), diaphragm, lungs, pleura, and other distant organs.

5.2 ASRM/AFS Classification

Laparoscopy is the gold standard for diagnosis and staging. The revised American Society for Reproductive Medicine (ASRM, formerly AFS) scoring system is used to classify disease severity based on the location, size, and depth of implants and adhesions.

Stage I (Minimal): 1–5 points
Stage II (Mild): 6–15 points
Stage III (Moderate): 16–40 points
Stage IV (Severe): >40 points

Complete obliteration of the posterior cul-de-sac automatically assigns a score of 40. Laparoscopic appearances range from classic "powder-burn" lesions to subtle red, white, or clear areas.

6. Clinical Presentation: Symptoms and Signs

6.1 Symptoms

The classic triad includes:

Dysmenorrhea: Progressively worsening secondary dysmenorrhea, often starting before menses and continuing after.
Infertility: Affects 40-50% of patients due to ovarian dysfunction, distorted tubo-ovarian anatomy, and an inflammatory peritoneal environment.
Dyspareunia: Deep, painful intercourse, often associated with nodules in the pouch of Douglas or a fixed, retroverted uterus.

Other symptoms include chronic pelvic pain, abnormal uterine bleeding, and organ-specific complaints like dyschezia (bowel involvement) or catamenial hemoptysis (thoracic involvement).

6.2 Signs

Physical examination may be normal, but key findings can include:

Bimanual Examination: Pelvic tenderness, nodularity in the pouch of Douglas or on uterosacral ligaments, a fixed and retroverted uterus, and adnexal masses (endometriomas) with restricted mobility.
Speculum Examination: May reveal bluish nodules in the posterior vaginal fornix.
Rectovaginal Examination: Essential for assessing posterior compartment disease.

7. Investigations

Serum Markers: CA-125 is non-specific and not diagnostic but may be elevated in severe disease and can be used to monitor therapy.
Imaging:
- Transvaginal Ultrasonography (TVS): The initial imaging modality, excellent for identifying endometriomas, which show a "ground-glass" appearance.
- Magnetic Resonance Imaging (MRI): The best non-invasive tool for assessing deep infiltrating endometriosis and for surgical planning.
Laparoscopy: The gold standard for definitive diagnosis, staging, biopsy, and concurrent surgical treatment.

8. Management of Endometriosis

Management is individualized based on the patient’s primary complaint (pain vs. infertility), age, symptom severity, and fertility desires.

8.1 Medical Therapy

Aims to induce amenorrhea and cause implant regression.

Combined Oral Contraceptives (COCs): Given continuously to induce a "pseudo-pregnancy" state.
Progestins: A mainstay of treatment (e.g., dienogest, norethisterone, medroxyprogesterone acetate).
GnRH Analogs (e.g., Leuprolide): Induce a "medical oophorectomy" or "pseudo-menopause" state. Highly effective but limited by hypoestrogenic side effects.
Danazol and Gestrinone: Effective but limited by androgenic side effects.
Aromatase Inhibitors (e.g., Letrozole): Reduce estrogen production.

8.2 Surgical Therapy

Indicated for severe symptoms, DIE, large endometriomas, or infertility when medical therapy fails.

Conservative Surgery: Aims to preserve fertility. Performed laparoscopically, it includes excision or ablation of implants, adhesiolysis, and restoration of normal anatomy.
- Endometrioma Management: Cystectomy (complete removal of the cyst wall) is the treatment of choice for endometriomas >4 cm, as it has the lowest recurrence rate.
Definitive Surgery: For women with severe disease who have completed their family.
- Total Hysterectomy with Bilateral Salpingo-Oophorectomy (BSO): The most effective treatment for long-term symptom relief. A multidisciplinary approach may be needed for severe DIE involving the bowel or ureters.

8.3 Management of Scar Endometriosis

Hormonal therapy is not effective. The treatment of choice is surgical excision of the nodule.

8.4 Recurrence

Endometriosis has a high recurrence rate (up to 40% within 5 years after conservative surgery). Long-term management and patient counseling are essential.

SURGICAL PEARLS:

A pelvic mass in a reproductive-aged woman that is tender and has restricted mobility should raise high suspicion for an endometrioma, distinguishing it from a mobile benign ovarian tumor.
During laparoscopy, train the eye to recognize subtle, atypical endometriotic lesions (red, white, clear areas, peritoneal defects), not just classic "powder-burn" spots.
Laparoscopy is both diagnostic and therapeutic. Be prepared to proceed with operative intervention (excision, adhesiolysis) during a diagnostic procedure for suspected endometriosis.
For ovarian endometriomas >4 cm, cystectomy is superior to simple drainage or vaporization. The larger size provides a better cleavage plane for dissecting the cyst wall from healthy ovarian stroma, minimizing recurrence.
For scar endometriosis, do not attempt medical management. Proceed directly to wide surgical excision, as it is the only effective treatment.

COMPLICATIONS AND THEIR MANAGEMENT:

Intraoperative: Bleeding; injury to adjacent structures like the bowel, bladder, or ureter, particularly in severe adhesive disease (DIE). This necessitates a high level of surgical skill and often a multidisciplinary team.
Early Postoperative: Infection, hematoma formation.
Late Postoperative: Adhesion reformation; disease recurrence, which is the most significant long-term issue. Recurrence requires restarting medical therapy or considering definitive surgery. Diminished ovarian reserve can occur following ovarian cystectomy.

MEDICOLEGAL AND PATIENT SELECTION CONSIDERATIONS:

Treatment for endometriosis must be individualized. A detailed discussion regarding symptoms, fertility desires, and the pros and cons of each treatment option is mandatory for informed consent.
Patients must be counseled that conservative medical and surgical therapies manage the disease but do not cure it. The high probability of recurrence must be clearly communicated.
The AFS/ASRM staging system provides an objective record of disease extent but does not correlate well with pain symptoms, a crucial point for patient counseling.
For surgery involving deep infiltrating endometriosis, the potential risks, including bowel or ureteric injury and the possibility of a stoma, require thorough preoperative counseling and a multidisciplinary surgical team.

SUMMARY AND TAKE-HOME MESSAGES:

Endometriosis is a chronic, invasive, benign disease with a multifactorial etiology, classically presenting with progressive dysmenorrhea, infertility, and deep dyspareunia.
Laparoscopy is the gold standard for diagnosis and staging, allowing for concurrent surgical treatment. The ASRM system classifies severity but does not predict symptoms.
Management must be tailored to the individual, balancing pain relief, fertility goals, and long-term disease suppression. Medical therapies induce amenorrhea, while surgery aims to restore anatomy.
Laparoscopic cystectomy is the preferred treatment for endometriomas >4 cm. Scar endometriosis requires surgical excision.
Given the high recurrence rate after conservative treatment, endometriosis should be managed as a chronic disease requiring a long-term strategy and comprehensive patient counseling.

MULTIPLE CHOICE QUESTIONS (MCQs):

What are the definitive histological components required to diagnose endometriosis?

a) Endometrial glands only

b) Endometrial stroma only

c) Both endometrial glands and stroma

d) Necrotic tissue with hemosiderin-laden macrophages
Sampson's theory, the most widely accepted explanation for endometriosis, is based on which mechanism?

a) Coelomic metaplasia of peritoneal cells

b) Lymphatic dissemination of endometrial tissue

c) Retrograde flow of viable menstrual tissue through the fallopian tubes

d) Iatrogenic implantation during surgery
A 32-year-old patient presents with progressively worsening secondary dysmenorrhea, deep dyspareunia, and infertility. This clinical picture is the classic triad for:

a) Pelvic Inflammatory Disease

b) Uterine Fibroids

c) Polycystic Ovarian Syndrome

d) Endometriosis
What is the characteristic sonographic appearance of an ovarian endometrioma on transvaginal ultrasound?

a) A simple, anechoic cyst with posterior acoustic enhancement

b) A multilocular cyst with solid components and high vascularity

c) A unilocular cyst with diffuse, low-level internal echoes ("ground-glass" appearance)

d) A hyperechoic, solid ovarian mass
According to the ASRM staging system, what is the automatic score assigned for complete obliteration of the posterior cul-de-sac?

a) 15

b) 25

c) 40

d) 60
Which of the following is considered the gold standard for the diagnosis of endometriosis?

a) Serum CA-125 levels

b) Magnetic Resonance Imaging (MRI)

c) Clinical history and physical examination

d) Laparoscopy with direct visualization and biopsy
The primary mechanism of action of GnRH analogs in treating endometriosis is:

a) Inducing a "pseudo-pregnancy" state

b) Creating a state of "medical oophorectomy" via pituitary downregulation

c) Direct competitive inhibition of progesterone receptors

d) Blocking local aromatase activity in endometriotic implants
What is the recommended surgical management for a 5 cm ovarian endometrioma in a patient desiring future fertility?

a) Simple aspiration and irrigation of the cyst

b) Laparoscopic cystectomy with removal of the entire cyst wall

c) Cyst wall vaporization with a laser

d) Oophorectomy to prevent recurrence
Which of the following is a key paradoxical feature of endometriosis?

a) It is a malignant disease that responds to hormonal therapy

b) It is a benign disease histologically but can be locally invasive and disseminate

c) It is stimulated by continuous hormonal therapy and suppressed by cyclical hormones

d) The extent of disease is always directly proportional to symptom severity
A patient develops a painful, cyclical nodule in her previous cesarean section scar. What is the most appropriate management?

a) A 6-month course of continuous oral contraceptives

b) Treatment with a GnRH analog

c) Surgical excision of the nodule

d) Expectant management with NSAIDs
Deep infiltrating endometriosis (DIE) is defined as endometriotic lesions penetrating to a depth of:

a) More than 2 mm

b) More than 5 mm

c) More than 1 cm

d) Through the full thickness of the organ
A physical examination finding of a fixed, retroverted uterus with nodularity on the uterosacral ligaments is highly suggestive of:

a) Ovarian torsion

b) An uncomplicated uterine myoma

c) Endometriosis with posterior compartment involvement

d) Acute salpingitis
Which theory best explains the rare presence of endometriosis in the lungs or pleura?

a) Direct Implantation Theory

b) Coelomic Metaplasia Theory

c) Retrograde Menstruation Theory

d) Lymphatic and Vascular Dissemination Theory (Halban's)
What is the approximate prevalence of endometriosis among women being evaluated for infertility?

a) 5-10%

b) 15-25%

c) 30-45%

d) 50-60%
The main disadvantage of using Danazol for endometriosis treatment is its:

a) High cost

b) Lack of efficacy for pain

c) Requirement for intravenous administration

d) Significant androgenic side effects
Which of the following is NOT a risk factor for developing endometriosis?

a) Early menarche

b) High parity (multiple childbirths)

c) Family history of endometriosis

d) Delayed childbearing
The primary objective of medical therapy for endometriosis-associated pain is to:

a) Permanently eradicate all endometriotic implants

b) Induce a state of amenorrhea, leading to lesion regression

c) Dissolve pelvic adhesions

d) Improve fallopian tube patency
"Kissing ovaries" is a laparoscopic finding characteristic of which stage of endometriosis?

a) Stage I (Minimal)

b) Stage II (Mild)

c) Stage III (Moderate)

d) Stage IV (Severe)
A definitive surgical cure for endometriosis, typically reserved for patients who have completed childbearing, is:

a) Laparoscopic presacral neurectomy

b) Conservative excision of all visible lesions

c) Total hysterectomy with bilateral salpingo-oophorectomy

d) Bilateral uterine artery embolization
What is the relationship between the ASRM/AFS stage of endometriosis and the patient's level of pain?

a) The stage is directly proportional to the pain level

b) There is a poor correlation between the stage and symptom severity

c) Stage I and II are always more painful than Stage III and IV

d) The stage only correlates with infertility, not with pain

Answer Key:

c, 2. c, 3. d, 4. c, 5. c, 6. d, 7. b, 8. b, 9. b, 10. c, 11. b, 12. c, 13. d, 14. c, 15. d, 16. b, 17. b, 18. d, 19. c, 20. b

MOTIVATIONAL MESSAGE FROM DR. R. K. MISHRA:

"The elegance of surgery is found not in speed, but in the economy of motion born from deep knowledge and deliberate practice. Let every step be precise, every decision be sound, and every action be guided by an unwavering commitment to the well-being of the patient on your table."

May your hands remain steady, your mind sharp, and your dedication to this noble craft bring healing and hope to those you serve. My best wishes are with you all.